Search results
Study Reveals Reversible Assembly of Platinum Catalyst
Newswise· 18 hours agoThe new understanding may offer clues to the catalyst’s stability and recyclability. The work, described in a paper just published in the journal Nanoscale, reveals how single platinum atoms ...
Vivacelle Bio's President and Chief Innovation Officer to Present Data Highlighting the Company's...
KTBS Shreveport· 3 days agoVivacelle's pipeline is led by VBI-S, a Phase 3-ready asset designated for the treatment of hypotension and hypovolemia in septic shock patients, and VBI-1, a Phase 2-ready candidate for hemorrhagic ...
Points To Consider For Assessing Lipid Quality For Lipid Nanoparticle Manufacturing
BioresearchOnline· 6 days agoLipid nanoparticles have generated a ton of buzz, but they pose risks that, perhaps, industry and...
EMA Panel Nods to Seven New Cancer Drugs
Medscape· 4 days agoThe drugs include an anti–PD-L1 monoclonal antibody, a biosimilar, and five generics, with indications covering a wide spectrum of cancers.
Vaccination induces broadly neutralizing antibody precursors to HIV gp41 - Nature Immunology
Nature· 5 days agoSchief and colleagues show that germline-targeting epitope scaffolds can elicit responses from rare broadly neutralizing antibody precursor B cells with predefined binding specificities and genetic features.
CAR T-Cell Therapy Could Be A Gamechanger For Autoimmune Diseases
Forbes· 5 days agoA recent study in the New England Journal of Medicine grabbed the attention of the medical community...
20-Year-Old Puzzle Solved: Physicists Reveal the “Three-Dimensional Vortex” of Zero-Dimensional...
SciTechDaily· 2 days agoA KAIST-led research team has successfully demonstrated the internal three-dimensional polarization...
7 Stocks You Haven't Heard of (That EVERYONE Should Own)
InvestorPlace· 5 days agoThere are many must-own stocks beyond the mega-caps that aren’t household names but have solid...
Aadi Bioscience to Participate in the Jefferies Healthcare Conference
The Yuma Sun· 5 days agoAadi Bioscience, Inc. (NASDAQ: AADI), a commercial-stage precision oncology company focused on developing and commercializing therapies for cancers with alterations in the mTOR pathway, announced ...
Affinity gaps among B cells in germinal centers drive the selection of MPER precursors - Nature...
Nature· 5 days agoBatista, Schief and colleagues use a series of germline-targeting immunogens in knock-in mice expressing heavy chain sequences derived from the HIV broadly neutralizing antibody 10E8 to characterize ...
